VIRALEZE SPL7013 virucidal (>99.99%) against Delta variant
- Written by PR Newswire
- New antiviral testing demonstrates SPL7013, the antiviral agent in VIRALEZE™ nasal spray, has potent virucidal activity against the globally significant Delta variant of SARS-CoV-2, reducing infectivity of the virus by >99.99% after 30 seconds of exposure
- SPL7013, the antiviral agent in VIRALEZE™, has now been shown in laboratory...
